G250 h(CD28-FcεRIγ) CAR, [T]
- Check with publisher
- Published date: December 26, 2019
-
- Shirley, New York, United States
The vector of anti-G250 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human G250. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-G250 antibody linked to a CD28 transmembrane domain/ endodomain and FcεRIγ signaling domains. And the vector product was designed for modifying T lymphocytes, and the modified T lymphocytes was designed for renal carcinoma treatment.https://www.creative-biolabs.com/car-t/pcdcar1-g250-h-28fc%CE%B5ri%CE%B3-t-790.htm










Useful information
- Avoid scams by acting locally or paying with PayPal
- Never pay with Western Union, Moneygram or other anonymous payment services
- Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
- This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"
Related listings
-
G250 h(CD28-CD3ζ) CAR, [T]
Cell Biology & Microbiology Shirley (New York) December 26, 2019 Check with publisherThe vector of anti-G250 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human G250. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-G250 antibody linke...
-
G250 h(CD28-41BB-CD3ζ) CAR, [T]
Cell Biology & Microbiology Shirley (New York) December 26, 2019 Check with publisherThe vector of anti-G250 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human G250. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-G250 antibody linke...
-
G250 h(b2c-CD3ζ) CAR, [T]
Cell Biology & Microbiology Shirley (New York) December 26, 2019 Check with publisherThe vector of anti-G250 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human G250. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-G250 antibody linke...